The advent of personalized medicine has revolutionized the whole approach to the
management of asthma, representing the essential basis for future developments. The …

Asthma is a heterogenous disease characterized by multiple phenotypes driven by different
mechanisms. The implementation of precision medicine in the management of asthma …

Asthma is a chronic disease characterized by airway inflammation, bronchial
hyperresponsiveness, and recurrent episodes of reversible airway obstruction. The disease …

Contemporary asthma management requires a proactive and individualized approach,
combining precision diagnosis and personalized treatment. The introduction of biologic …

Objective Severe asthma is associated with substantial personal and economic burden;
maintaining disease control is the key management goal. Increased understanding of …

A plethora of biomarkers are becoming available in the field of respiratory medicine, but their
application in clinical practice has been limited. This is changing. There is increasing scope …

Biomarkers may be a key foundation for the precision medicine of the future. In this article,
we review current knowledge regarding biomarkers in difficult‐to‐treat asthma and their …

Many studies have assessed sputum eosinophil percentage as a phenotypic descriptor in
asthma patients. Adjusting inhaled corticosteroid (ICS) dose based on sputum eosinophilia …

Introduction: We argue that asthma be considered a syndrome caused by multiple
inflammatory pathogenic processes. Bronchial hyperresponsiveness, reversible airflow …

Individualisation of asthma treatment regimens on the basis of biomarkers is necessary to
improve asthma control. However, the suboptimal properties of currently available …